Sol Gel Technologies Ltd (SLGL) Stock Analysis

AI analysis of Sol Gel Technologies Ltd (SLGL)

Hold

Currently, Sol Gel Technologies Ltd is not a strong buy. The stock is priced at $65.69, which is significantly lower than the analyst price target of $285, indicating potential upside. However, the RSI is at 32.40, suggesting the stock is oversold, and it has a forward P/E ratio of 9.34, which is attractive. The main risk is the recent financial performance, as the company reported a net loss of $3.68 million for Q2 2026, a stark contrast to a net income of $11.61 million in the same quarter last year, highlighting significant volatility in earnings.

Analyst Ratings (4)

-24.24% Downside

Buy

4 Buy

0 Hold

0 Sell

Current: 66.00

Low

50.00

Average

50.00

High

50.00

Mizuho

Outperform

$285

2026-06-24

Mizuho

2026-06-24

Price Target

$285

Outperform

TD Cowen

Buy

—

2026-05-29

TD Cowen

2026-05-29

Price Target

—

Buy

H.C. Wainwright

Buy

$110

2026-01-20

H.C. Wainwright

2026-01-20

Price Target

$110

Buy

Raymond James

Buy

$4

2024-08-19

Raymond James

2024-08-19

Price Target

$4

Buy

HC Wainwright & Co.

Strong Buy

$6

2024-05-22

HC Wainwright & Co.

2024-05-22

Price Target

$6

Strong Buy

See All Ratings

Valuation Metrics

The current forward P/E ratio for Sol Gel Technologies Ltd (SLGL) is 9.34, compared to its 5-year average forward P/E of -7.14.

Forward P/E

Fair

5Y Average P/E

-7.14

Current P/E

9.34

Overvalued

12.49

Undervalued

-26.76

Forward EV/EBITDA

Undervalued

5Y Average EV/EBITDA

-10.60

Current EV/EBITDA

-50.17

Overvalued

18.17

Undervalued

-39.37

Forward P/S

Strongly Overvalued

5Y Average P/S

42.01

Current P/S

381.32

Overvalued

148.59

Undervalued

-64.58

Alphio AI Price Scenarios for SLGL

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%SLGL

$25.08

Scenario price

B

Base

Base · 50%SLGL

$16.82

Scenario price

B

Bear

Bear · 25%SLGL

$8.25

Scenario price

Whales holding SLGL

P

Phoenix Investments & Finances Ltd

+ HoldingSLGL

-2.54%

3M Return

Y

Yelin Lapidot Holdings Ltd.

+ HoldingSLGL

-10.27%

3M Return

SLGL FAQ — answered by Alphio AI

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).

Currently, Sol Gel Technologies Ltd is not a strong buy. The stock is priced at $65.69, which is significantly lower than the analyst price target of $285, indicating potential upside. However, the RSI is at 32.40, suggesting the stock is oversold, and it has a forward P/E ratio of 9.34, which is attractive. The main risk is the recent financial performance, as the company reported a net loss of $3.68 million for Q2 2026, a stark contrast to a net income of $11.61 million in the same quarter last year, highlighting significant volatility in earnings.

4 analysts cover SLGL: 4 rate it Buy, 0 Hold and 0 Sell. The average price target is 50.00.